Log in to save to my catalogue

Doxycycline host-directed therapy in human pulmonary tuberculosis

Doxycycline host-directed therapy in human pulmonary tuberculosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2557556880

Doxycycline host-directed therapy in human pulmonary tuberculosis

About this item

Full title

Doxycycline host-directed therapy in human pulmonary tuberculosis

Publisher

Ann Arbor: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2021-08, Vol.131 (15), p.1-14

Language

English

Formats

Publication information

Publisher

Ann Arbor: American Society for Clinical Investigation

More information

Scope and Contents

Contents

BACKGROUND. Matrix metalloproteinases (MMPs) are key regulators of tissue destruction in tuberculosis (TB) and may be targets for host-directed therapy. We conducted a phase II double-blind, randomized, controlled trial investigating doxycycline, a licensed broad-spectrum MMP inhibitor, in patients with pulmonary TB. METHODS. Thirty patients with p...

Alternative Titles

Full title

Doxycycline host-directed therapy in human pulmonary tuberculosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2557556880

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2557556880

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI151668

How to access this item